Abstract
Despite the global advancement in availability of modern diagnostic tools and a variety of therapeutic modalities, many diseases have still been on the rise worldwide. Animal models serve as a valuable means in conducting preclinical research related to various human diseases including cancer. These models assist not only to understand the underlying genetic mechanism of a tumor but also the impact of several crucial genes that quite often gets mutated leading to deadly cancers. Scientists are striving for regulated and customized animal models which mimic the real cancers in human beings in their growth and development. For developing animal models of cancer, a variety of animals and personalized as well as precision medicine methods are being used to cater the demand of different patients. Of these animal models of cancer, several mice models have been used worldwide due to their uniqueness in mimicking human cancers. Here, we have discussed about the major benefits and constraints related with the use of such models.
This is a preview of subscription content, log in via an institution to check access.
References
Adam SJ, Rund LA, Kuzmuk KN et al (2006) Genetic induction of tumorigenesis in swine. Oncogene 26:1038–1045. https://doi.org/10.1038/sj.onc.1209892
Alvarez CE (2014) Naturally occurring cancers in dogs: insights for translational genetics and medicine. ILAR J 55:16–45. https://doi.org/10.1093/ilar/ilu010
Antinucci P, Hindges R (2016) A crystal-clear zebrafish for in vivo imaging. Sci Rep. https://doi.org/10.1038/srep29490
Aparicio S, Hidalgo M, Kung AL (2015) Examining the utility of patient-derived xenograft mouse models. Nat Rev Cancer 15:311–316. https://doi.org/10.1038/nrc3944
Baxter VK, Griffin DE (2016) Animal models. Viral Pathogen:125, 138. https://doi.org/10.1016/b978-0-12-800964-2.00010-0
Bojovic B, Crowe DL (2011) Telomere dysfunction promotes metastasis in a TERC null mouse model of head and neck cancer. Mol Cancer Res 9:901–913. https://doi.org/10.1158/1541-7786.mcr-10-0345
Bosma GC, Custer RP, Bosma MJ (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301:527–530. https://doi.org/10.1038/301527a0
Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries, 394. CA Cancer J Clin 68:–424. https://doi.org/10.3322/caac.21492
Byrne AT, Alférez DG, Amant F et al (2017) Interrogating open issues in cancer precision medicine with patient-derived xenografts. Nat Rev Cancer 17:254–268. https://doi.org/10.1038/nrc.2016.140
Calbo J, van Montfort E, Proost N et al (2011) A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer. Cancer Cell 19:244–256. https://doi.org/10.1016/j.ccr.2010.12.021
Cheon D-J, Orsulic S (2011) Mouse models of cancer. Ann Rev Pathol: Mech Dis 6:95–119. https://doi.org/10.1146/annurev.pathol.3.121806.154244
Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, Cordon-Cardo C, Pandolfi PP (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436(7051):725–30. https://doi.org/10.1038/nature03918. PMID: 16079851; PMCID: PMC1939938
Dahm R, Geisler R, Nüsslein-Volhard, C (2006) Zebrafish (Danio rerio) genome and genetics. Encyclopedia of molecular cell biology and molecular medicine. 2nd Edition. 15:593–626
DuPage M, Cheung AF, Mazumdar C et al (2011) Endogenous t cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression. Cancer Cell 19:72–85. https://doi.org/10.1016/j.ccr.2010.11.011
Eastmond DA, Vulimiri SV, French JE, Sonawane B (2013) The use of genetically modified mice in cancer risk assessment: challenges and limitations. Crit Rev Toxicol 43:611–631. https://doi.org/10.3109/10408444.2013.822844
Feitsma H, Cuppen E (2008) Zebrafish as a cancer model. The american association for cancer research. Mol Cancer Res 6:685–694. https://doi.org/10.1158/1541-7786.MCR-07-2167
Flisikowska T, Kind A, Schnieke A (2016) Pigs as models of human cancers. Theriogenology 86:433–437. https://doi.org/10.1016/j.theriogenology.2016.04.058
Fogh J, Fogh JM, Orfeo T (1977) One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. JNCI: J Natl Cancer Inst 59(1):221–226. https://doi.org/10.1093/jnci/59.1.221
Gawrylewski A (2007) The trouble with animal models. Scientist (Philadelphia, Pa.). 21:45–51
Germano G, Lamba S, Rospo G et al (2017) Inactivation of DNA repair triggers neoantigen generation and impairs tumor growth. Nature 552:116–120. https://doi.org/10.1038/nature24673
Goodman AM, Kato S, Bazhenova L, Patel SP, Frampton GM, Miller V, Stephens PJ, Daniels GA, Kurzrock R (2017) Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers. Mol Cancer Ther 16(11):2598–2608. https://doi.org/10.1158/1535-7163.MCT-17-0386. Epub 2017 Aug 23. PMID: 28835386; PMCID: PMC5670009
Greenberg NM, DeMayo F, Finegold MJ et al (1995) Prostate cancer in a transgenic mouse. Proc Natl Acad Sci 92:3439–3443. https://doi.org/10.1073/pnas.92.8.3439
Gulley JL, Drake CG (2011) Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research. Clin Cancer Res 17:3884–3891. https://doi.org/10.1158/1078-0432.ccr-10-2656
Hackam DG, Redelmeier DA (2006) Translation of research evidence from animals to humans. JAMA 296(14):1731–2. https://doi.org/10.1001/jama.296.14.1731. PMID: 17032985
Hammer RE, Pursel VG, Rexroad CE et al (1985) Production of transgenic rabbits, sheep and pigs by microinjection. Nature 315:680–683. https://doi.org/10.1038/315680a0
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Harfouche R, Basu S, Soni S, Hentschel DM, Mashelkar RA, Sengupta S (2009) Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis. Angiogenesis 12(4):325–338
Hasgur S, Aryee KE, Shultz LD et al (2016) Generation of immunodeficient Mice Bearing human immune systems by The Engraftment of hematopoietic stem cells. Methods Mol Biol:67–78. https://doi.org/10.1007/978-1-4939-3661-8_4
Hason M, Bartůněk P (2019) Zebrafish models of cancer—new insights on modeling human cancer in a non-mammalian vertebrate. Genes 10:935. https://doi.org/10.3390/genes10110935
Hidalgo M, Amant F, Biankin AV et al (2014) Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov 4:998–1013. https://doi.org/10.1158/2159-8290.cd-14-0001
Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, Hruban RH, Rustgi AK, Chang S, Tuveson DA (2005) Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7(5):469–83. https://doi.org/10.1016/j.ccr.2005.04.023. PMID: 15894267
Hoffe B, Holahan MR (2019) The use of pigs as a translational model for studying neurodegenerative diseases. Front Physiol. https://doi.org/10.3389/fphys.2019.00838
Hooijkaas AI, Gadiot J, van der Valk M, Mooi WJ, Blank CU (2012) Targeting BRAFV600E in an inducible murine model of melanoma. Am J Pathol 181(3):785–94. https://doi.org/10.1016/j.ajpath.2012.06.002. Epub 2012 Jul 11. PMID: 22796458
Hu Z, Yang Y-G (2012) Human lymphohematopoietic reconstitution and immune function in immunodeficient mice receiving cotransplantation of human thymic tissue and cd34+ cells. Cell Mol Immunol 9:232–236. https://doi.org/10.1038/cmi.2011.63
Ito M, Hiramatsu H, Kobayashi K et al (2002) NOD/SCID/γcnull mouse: an EXCELLENT RECIPIENT mouse model FOR engraftment of human cells. Blood 100:3175–3182. https://doi.org/10.1182/blood-2001-12-0207
Itoh M, Mukae Y, Kitsuka T et al (2019) Development of an immunodeficient pig model allowing long-term accommodation of artificial human vascular tubes. Nat Commun. https://doi.org/10.1038/s41467-019-10107-1
Jing Y, Wang G, Xiao Q et al (2018) Antiangiogenic effects of AA-PMe on HUVECS in vitro and Zebrafish in vivo. Onco Targets Ther 11:1871–1884. https://doi.org/10.2147/ott.s157747
Jun E, Hong S-M, Yoo HJ et al (2017) Genetic and metabolic comparison of orthotopic and heterotopic patient-derived pancreatic-cancer xenografts to the original patient tumors. Oncotarget 9:7867–7881. https://doi.org/10.18632/oncotarget.23567
Ku SY, Rosario S, Wang Y et al (2017) Rb1 and TRP53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance. Science 355:78–83. https://doi.org/10.1126/science.aah4199
Landgraf M, McGovern JA, Friedl P, Hutmacher DW (2018) Rational design of mouse models for cancer research. Trends Biotechnol 36:242–251. https://doi.org/10.1016/j.tibtech.2017.12.001
Liu C, Zhang Y, Lim S et al (2017) A zebrafish model discovers a novel mechanism of stromal fibroblast-mediated cancer metastasis. Clin Cancer Res 23:4769–4779. https://doi.org/10.1158/1078-0432.ccr-17-0101
Lunney JK (2007) Advances in swine biomedical model genomics. Int J Biol Sci:179–184. https://doi.org/10.7150/ijbs.3.179
MacEwen EG (1990) Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastasis Rev:125–136. https://doi.org/10.1007/bf00046339
McGrath P, Li C-Q (2008) Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discov. Today 13:394–401
Madan RA, Gulley JL, Fojo T, Dahut WL (2010) Therapeutic cancer vaccines in prostate cancer: the paradox of improved survival without changes in time to progression. Oncologist 15:969–975. https://doi.org/10.1634/theoncologist.2010-0129
Makohon-Moore A, Iacobuzio-Donahue CA (2016) Pancreatic cancer biology and genetics from an evolutionary perspective. Nat Rev Cancer 16:553–565. https://doi.org/10.1038/nrc.2016.66
Mombaerts P, Iacomini J, Johnson RS et al (1992) Rag-1-deficient mice have no mature b and t lymphocytes. Cell 68:869–877. https://doi.org/10.1016/0092-8674(92)90030-g
Murayama T, Gotoh N (2019) Patient-derived xenograft models of breast cancer and their application. Cell 8:621. https://doi.org/10.3390/cells8060621
Myers MJ, Farrell DE, Howard KD, Kawalek JC (2010) Effects of intravenous administration of lipopolysaccharide on cytochrome p450 isoforms and hepatic drug metabolizing enzymes in swine. Am J Vet Res 71:342–348. https://doi.org/10.2460/ajvr.71.3.342
Nicoli S, Ribatti D, Cotelli F, Presta M (2007) Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res 67:2927–2931. https://doi.org/10.1158/0008-5472.can-06-4268
Pajot A, Michel M-L, Fazilleau N et al (2004) A mouse model of human adaptive immune functions:HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice. Eur J Immunol 34:3060–3069. https://doi.org/10.1002/eji.200425463
Paula J. Kaplan-Lefko,Tsuey-Ming Chen, Michael M. Ittmann, Roberto J. Barrios, Gustavo E. Ayala, Wendy J. Huss, Lisette A. Maddison, Barbara A. Foster, Norman M. Greenberg (2003) Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 55:219–237. https://doi.org/10.1002/pros.10215
Peng J, Hamanishi J, Matsumura N, Abiko K, Murat K, Baba T, . . . Mandai M (2015) Chemotherapy induces programmed cell death-ligand 1 overexpression via the nuclear factor-ΚB to foster an immunosuppressive tumor microenvironment in ovarian cancer. Cancer Research 75(23):5034–5045. https://doi.org/10.1158/0008-5472.can-14-3098
Perleberg C, Kind A, Schnieke A (2018) Genetically engineered pigs as models for human disease. Dis Model Mech 11(1). https://doi.org/10.1242/dmm.030783
Perrin S (2014) Preclinical research: make mouse studies work. Nature 507:423–425. https://doi.org/10.1038/507423a
Platt RJ, Chen S, Zhou Y et al (2014) CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159:440–455. https://doi.org/10.1016/j.cell.2014.09.014
Prowse KR, Greider CW (1995) Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci 92:4818–4822. https://doi.org/10.1073/pnas.92.11.4818
Puchalapalli M, Zeng X, Mu L et al (2016) NSG mice provide a better spontaneous model of breast cancer metastasis than athymic (nude) mice. PLoS One. https://doi.org/10.1371/journal.pone.0163521
Puig I, Chicote I, Tenbaum SP et al (2013) A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells. Clin Cancer Res 19:6787–6801. https://doi.org/10.1158/1078-0432.ccr-12-1740
Ressel L, Millanta F, Caleri E et al (2009) Reduced pten protein expression and its prognostic implications in canine and feline mammary tumors. Vet Pathol 46:860–868. https://doi.org/10.1354/vp.08-vp-0273-p-fl
Rubio R, GarcÃa-Castro J, Gutiérrez-Aranda I et al (2010) Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates Leiomyosarcoma in vivo. Cancer Res 70:4185–4194. https://doi.org/10.1158/0008-5472.can-09-4640
Saalfrank A, Janssen K-P, Ravon M et al (2016) A porcine model of osteosarcoma. Oncogenesis. https://doi.org/10.1038/oncsis.2016.19
Schachtschneider KM, Madsen O, Park C et al (2015) Adult porcine genome-wide DNA methylation patterns support pigs as a biomedical model. BMC Genomics 16:743. https://doi.org/10.1186/s12864-015-1938-x
Schachtschneider KM, Schwind RM, Newson J et al (2017) The oncopig cancer model: an innovative large animal translational oncology platform. Front Oncol. https://doi.org/10.3389/fonc.2017.00190
Schook LB, Collares TV, Darfour-Oduro KA et al (2015) Unraveling the swine genome: implications for human health. Ann Rev Anim Biosci 3:219–244. https://doi.org/10.1146/annurev-animal-022114-110815
Schreiber RD, Old LJ, Smyth MJ (2011) Cancer Immunoediting: integrating Immunity’s roles in cancer suppression and promotion. Science 331:1565–1570. https://doi.org/10.1126/science.1203486
Sena ES, van der Worp HB, Bath PMW, Howells DW, Macleod MR (2010) Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol 8(3):e1000344. https://doi.org/10.1371/journal.pbio.1000344
Shackleton M, Quintana E, Fearon ER, Morrison SJ (2009) Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138:822–829. https://doi.org/10.1016/j.cell.2009.08.017
Shibata H, Toyama K, Shioya H, Ito M, Hirota M, Hasegawa S, Matsumoto H, Takano H, Akiyama T, Toyoshima K, Kanamaru R, Kanegae Y, Saito I, Nakamura Y, Shiba K, Noda T (1997) Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 278(5335):120–3. https://doi.org/10.1126/science.278.5335.120. PMID: 9311916
Shinkai Y (1992) RAG-2-deficient mice lack mature lymphocytes owing to inability to INITIATE V(D)J rearrangement. Cell 68:855–867. https://doi.org/10.1016/0092-8674(92)90029-c
Shultz LD, Ishikawa F, Greiner DL (2007) Humanized mice in translational biomedical research. Nat Rev Immunol 7:118–130. https://doi.org/10.1038/nri2017
Siegler EL, Wang P (2018) Preclinical models in chimeric antigen receptor–engineered t-cell therapy. Hum Gene Ther 29:534–546. https://doi.org/10.1089/hum.2017.243
Sinn E, Muller W, Pattengale P, et al. (1987) Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49(4):465–475
Suzuki S, Iwamoto M, Saito Y et al (2012) Il2rg gene-targeted severe combined immunodeficiency pigs. Cell Stem Cell 10:753–758. https://doi.org/10.1016/j.stem.2012.04.021
Tian X, Lv D, Ma T et al (2018) AANAT transgenic sheep generated via OPS vitrified-microinjected pronuclear embryos and reproduction efficiency of the transgenic offspring. PeerJ. https://doi.org/10.7717/peerj.5420
Uno T, Takeda K, Kojima Y et al (2006) Eradication of established tumors in mice by a combination antibody-based therapy. Nat Med 12:693–698. https://doi.org/10.1038/nm1405
Walrath JC, Hawes JJ, Van Dyke T, Reilly KM (2010) Genetically engineered mouse models in cancer research. Adv Cancer Res:113–164. https://doi.org/10.1016/s0065-230x(10)06004-5
Walsh NC, Kenney LL, Jangalwe S et al (2017) Humanized mouse models of clinical disease. Ann Rev Pathol Mech Dis 12:187–215. https://doi.org/10.1146/annurev-pathol-052016-100332
Wang J, Cao Z, Zhang X-M et al (2014) Novel mechanism of macrophage-mediated metastasis revealed in a zebrafish model of tumor development. Cancer Res 75:306–315. https://doi.org/10.1158/0008-5472.can-14-2819
Wang K, Jin Q, Ruan D et al (2017) Cre-dependent cas9-expressing pigs enable efficient in vivo genome editing. Genome Res 27:2061–2071. https://doi.org/10.1101/gr.222521.117
Watanabe M, Nakano K, Matsunari H et al (2013) Generation of interleukin-2 receptor gamma gene knockout pigs from somatic cells genetically modified by zinc finger nuclease-encoding mRNA. PLoS One 8(10):e76478. https://doi.org/10.1371/journal.pone.0076478
Watson AL, Carlson DF, Largaespada DA et al (2016) Engineered swine models of cancer. Front Genet 7:78. https://doi.org/10.3389/fgene.2016.00078
White RM, Sessa A, Burke C et al (2008) Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2:183–189. https://doi.org/10.1016/j.stem.2007.11.002
Wild CP (2019) The global cancer burden: necessity is the mother of prevention. Nat Rev Cancer 19:123–124. https://doi.org/10.1038/s41568-019-0110-3
Wright MH, Robles AI, Herschkowitz JI et al (2008) Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for brca1. Mol Cancer 7:29. https://doi.org/10.1186/1476-4598-7-29
Xu C, Li X, Liu P et al (2018) Patient derived xenograft mouse models: a high fidelity tool for individualized medicine (review). Oncol Lett. https://doi.org/10.3892/ol.2018.9583
Xu C, Wu S, Schook LB, Schachtschneider KM (2019) Translating human cancer sequences into personalized porcine cancer models. Front Oncol. https://doi.org/10.3389/fonc.2019.00105
Yang Y-G, Sykes M (2007) Xenotransplantation: current status and a perspective on the future. Nat Rev Immunol 7:519–531. https://doi.org/10.1038/nri2099
Yarchoan M, Johnson BA, Lutz ER et al (2017) Targeting neoantigens to augment antitumor immunity. Nat Rev Cancer 17:209–222. https://doi.org/10.1038/nrc.2016.154
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Sharma, G., Goyal, Y., Bhatia, S. (2022). Preclinical Animal Models of Cancer: Applications and Limitations. In: Pathak, S., Banerjee, A., Bisgin, A. (eds) Handbook of Animal Models and its Uses in Cancer Research. Springer, Singapore. https://doi.org/10.1007/978-981-19-1282-5_54-1
Download citation
DOI: https://doi.org/10.1007/978-981-19-1282-5_54-1
Received:
Accepted:
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-1282-5
Online ISBN: 978-981-19-1282-5
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences